Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Leif Bjermer, Isabelle H Boucot, François Maltais, Edward M Kerwin, Ian P Naya, Lee Tombs, Paul W Jones, Chris Compton, David A Lipson & Claus F Vogelmeier. (2021) Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1939-1956.
Read now
Read now
Robert M Burkes & Ralph J Panos. (2020) Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease. Journal of Experimental Pharmacology 12, pages 589-602.
Read now
Read now
Andrea S. Melani. (2018) Olodaterol for the treatment of chronic obstructive pulmonary disease: a narrative review. Expert Opinion on Pharmacotherapy 19:14, pages 1603-1611.
Read now
Read now
Nicolas Roche. (2018) Stable COPD Treatment: Where are We?. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:2, pages 123-129.
Read now
Read now
Gaetano Caramori, Paolo Ruggeri, Paolo Casolari, Kian Fan Chung, Giuseppe Girbino & Ian M. Adcock. (2017) Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 11:12, pages 955-967.
Read now
Read now
Peter M. A. Calverley, Helgo Magnussen, Marc Miravitlles & Jadwiga A. Wedzicha. (2017) Triple Therapy in COPD: What We Know and What We Don't. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:6, pages 648-662.
Read now
Read now
Articles from other publishers (19)
Hiroaki Kume, Ryuki Yamada & Yuki Sato. 2023. A Compendium of Chronic Obstructive Pulmonary Disease. A Compendium of Chronic Obstructive Pulmonary Disease.
Alberto Papi, Konstantinos Kostikas, Ivan Nikolaev & Ioannis Kottakis. (2022) Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A
Combination Therapy for Asthma. Current Respiratory Medicine Reviews 18:2, pages 77-85.
Crossref
Crossref
M. Zysman, B. Ribeiro Baptista, T. Soumagne, V. Marques da Silva, C. Martin, C. Thibault de Menonville, L. Boyer, B. Degano, C. Morelot Panzini, P.R. Burgel, T. Perez, A. Bourdin, C. Raherison, H. Pégliasco, D. Piperno, C. Zanetti, H. Morel, B. Delclaux, C. Delafosse, A. Lorenzo, B. Housset, F. Chabot, P. Devillier, G. Deslée & N. Roche. (2021) Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française. Actualisation 2021. Revue des Maladies Respiratoires 38:5, pages 539-561.
Crossref
Crossref
Z. R. Aisanov, S. N. Avdeev, A. S. Belevskiy, A. A. Vizel', A. V. Emel'yanov, G. L. Ignatova, O. M. Kurbacheva, I. V. Leshchenko, N. M. Nenasheva, S. I. Ovcharenko, A. I. Sinopal'nikov & O. N. Titova. (2021) The position of the fixed combination of indacaterol, glycopyrronium, and mometasone furoate in the management of bronchial asthma. The Report of Expert Panel of Russian Respiratory Society. PULMONOLOGIYA 31:1, pages 66-74.
Crossref
Crossref
Yee Vern Yong, Siti Hajar Mahamad Dom, Nurulmaya Ahmad Sa’ad, Rosliza Lajis, Faridah Aryani Md. Yusof & Jamalul Azizi Abdul Rahaman. (2021) Development and Practical Application of a Multiple-Criteria Decision Analysis Framework on Respiratory Inhalers: Is It Always Useful in the MOH Malaysia Medicines Formulary Listing Context?. MDM Policy & Practice 6:1, pages 238146832199406.
Crossref
Crossref
Hiroaki Kume. 2021. Lung Inflammation in Health and Disease, Volume I. Lung Inflammation in Health and Disease, Volume I
139
172
.
Hyun Woo Lee, Jimyung Park, Eun Jin Jang & Chang-Hoon Lee. (2020) Comparisons of exacerbations and mortality among LAMA/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis. Respiratory Research 21:1.
Crossref
Crossref
F. Maltais, I. P. Naya, C. F. Vogelmeier, I. H. Boucot, P. W. Jones, L. Bjermer, L. Tombs, C. Compton, D. A. Lipson & E. M. Kerwin. (2020) Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial. Respiratory Research 21:1.
Crossref
Crossref
S. N. Avdeev & Z. R. Aisanov. (2020) The new prospects of the inhalation therapy for bronchial asthma. PULMONOLOGIYA 30:4, pages 473-484.
Crossref
Crossref
Hiroaki Kume, Masayuki Hojo & Naozumi Hashimoto. (2019) Eosinophil Inflammation and Hyperresponsiveness in the Airways as Phenotypes of COPD, and Usefulness of Inhaled Glucocorticosteroids. Frontiers in Pharmacology 10.
Crossref
Crossref
Longxia Gao, Dongxu Si, Haipeng Bao, MingXia Yu, Huizhuo Sun, Dashzeveg Damchaaperenlei, Yue Yan, Qi Shi & Youlin Li. (2019) Tai Chi for the treatment of chronic obstructive pulmonary disease. Medicine 98:26, pages e16097.
Crossref
Crossref
I. D. Pelevina, N. L. Shaporova, O. V. Dudina, V. N. Yablonskaya & O. A. Lazovskaya. (2019) Management of chronic obstructive pulmonary disease patients quitting smoking: optimization the basic therapy. Russian Pulmonology 29:1, pages 52-60.
Crossref
Crossref
Chin Kook Rhee, Hajime Yoshisue & Rahul Lad. (2019) Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives. Advances in Therapy 36:3, pages 495-519.
Crossref
Crossref
Kenneth R. Chapman, John R. Hurst, Robert B. Fogel, Pascal Pfister, Konstantinos Kostikas & Jadwiga A. Wedzicha. (2019) Reply to Lan and Shi: Different Background, Short Duration, and Inappropriate Participants May Harm Your Conclusion. American Journal of Respiratory and Critical Care Medicine 199:3, pages 390-392.
Crossref
Crossref
Eneida M. Harrison & Victor Kim. (2019) Long-acting maintenance pharmacotherapy in chronic obstructive pulmonary disease. Respiratory Medicine: X 1, pages 100009.
Crossref
Crossref
Kenneth R. Chapman, John R. Hurst, Stefan-Marian Frent, Michael Larbig, Robert Fogel, Tadhg Guerin, Donald Banerji, Francesco Patalano, Pankaj Goyal, Pascal Pfister, Konstantinos Kostikas & Jadwiga A. Wedzicha. (2018) Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial. American Journal of Respiratory and Critical Care Medicine 198:3, pages 329-339.
Crossref
Crossref
In Ae Kim, Yong Bum Park & Kwang Ha Yoo. (2018) Pharmacotherapy for chronic obstructive pulmonary disease. Journal of the Korean Medical Association 61:9, pages 545.
Crossref
Crossref
Nicolas Roche, Kenneth R. Chapman, Claus F. Vogelmeier, Felix J. F. Herth, Chau Thach, Robert Fogel, Petter Olsson, Francesco Patalano, Donald Banerji & Jadwiga A. Wedzicha. (2017) Reply: What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?. American Journal of Respiratory and Critical Care Medicine 196:9, pages 1230-1231.
Crossref
Crossref
Mario Cazzola & Paola Rogliani. (2017) Comparative effectiveness of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease. Journal of Comparative Effectiveness Research 6:7, pages 627-636.
Crossref
Crossref